Herein we describe four cases of ruptured infected thoracic aortic aneurysm. All patients underwent emergent thoracic endovascular aortic repair to stabilize hemodynamics. After controlling infection, stent graft removal and in situ reconstruction with radical debridement were performed in all but one case. All patients survived during the median 31-month follow-up period, and only one exhibited infection reactivation, which occurred 294 days after initial endoaortic repair. Infected thoracic aortic aneurysm (ITAA) is a rare, lifethreatening disorder that can only be treated via surgery. Aneurysm rupture increases the perioperative mortality rate of ITAA. The main strategies used to treat ruptured ITAA at our institution are (1) emergent thoracic endovascular aortic repair (TEVAR) to stabilize hemodynamic status when the anatomy is conducive, (2) efficient administration of antibiotic and adjunctive procedures (eg, drainage of infective foci) for several weeks to control infection, and (3) in situ reconstruction after radical debridement of infected tissue. We reviewed the details of the cases presented herein to assess the outcomes of these strategies. All patients provided written informed consent for the publication of this case series. However, two of four patients treated using this strategy died within 3 months postoperatively. One of these deaths was due to aortic rupture at the site of anastomosis and the other was a case of unexplained sudden death. Therefore, the treatment strategies for ruptured ITAA were changed to those that we currently use. The TEVAR component was determined by the aortic team at our institution, and the TEVAR devices used were the GORE TAG (W.L. Gore and Associates, Flagstaff, Ariz) and Zenith TX2 (Cook Medical Inc., Bloomington, Ind). We retrospectively reviewed the cases of four patients who had undergone emergent TEVAR as a bridge before definitive open surgical repair since 2013. Table I summarizes the demographic characteristics of these four patients. All presented with fever and three experienced localized chest pain. Case 3 exhibited hemoptysis owing to aortobronchial fistula, but only case 2 exhibited a positive blood culture preoperatively.
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CASE REPORTS
CT findings suggested that all aneurysms were saccular. In addition, three of the four patients exhibited a single contained ruptured aneurysm. Case 3 exhibited multiple aneurysms, and one thoracic descending aortic aneurysm had ruptured into the bronchial tube (Fig 1, A) . Emergent TEVAR was performed immediately after admission (Fig 1, B) . In case 4, carotid-carotid bypass and retrograde in situ branched stent grafting were performed to preserve cerebral perfusion (Fig 2, A-C). 1 Although an antibiotic had been administered at admission, intravenous administration of effective antibiotics was initiated in accordance with recommendations from the infection control team at our institution. The details of case 2 have been reported previously. 2 In this case, a pigtail drainage catheter was placed into the aneurysmal cavity under CT guidance with daily irrigation using 0.02% gentian violet solution, which is reportedly highly effective against methicillin-resistant Staphylococcus aureus. 3 The median maximum C-reactive protein In case 4, in accordance with the patient's preference, secondstage surgery was not performed within weeks because the infection was controlled via continuous oral antibiotic administration. Surgery was performed 294 days after TEVAR in that case, however, because the distal aortic arch at the distal landing zone was expanding in conjunction with elevated inflammation (Fig 2, D and E) . The procedures used in each patient are shown in Table II .
The TEVAR strategy was discussed by the aortic team at our 
DISCUSSION
Although ruptured ITAA requires emergency surgery, patient condition is usually substantially compromised owing to active infection, which affects survival during conventional open surgery. The perioperative mortality rate in patients with a free ruptured ITAA is reportedly 37.5% to 100.0%. [4] [5] [6] Some recent studies have reported acceptable short-term outcomes of TEVAR for ITAA. Semba et al 7 reported the successful management of ruptured ITAAs with endovascular repair. Although TEVAR is a less invasive therapeutic option, particularly for aneurysmal rupture, implanting a foreign body in an infected field is a major concern. Ishida et al 8 reported a major type I endoleak the day after performing TEVAR, despite successful stent graft placement. They concluded that TEVAR for ruptured ITAA may be associated with a substantial risk of endoleak owing to active infection. Further, Kan et al 9 evaluated stent graft implantation of aneurysmal rupture, which is a significant independent predictor of persistent infection. We experienced a case wherein aortic diameter enlargement occurred in conjunction with placement of the inner stent graft in the late phase, which may have been caused by persistent infection. We believe the infection was difficult to control completely despite continued antibiotic administration after stent graft implantation for the ruptured ITAA. Hence, open surgical repair after bridging TEVAR is recommended as soon as possible after hemodynamic stability and infection control are achieved. Tamura et al 10 reported the first clinical case of the use of bridging TEVAR for infected 
CONCLUSIONS
Bridging TEVAR followed by definitive open surgical repair is feasible in patients with ruptured ITAA. Performing open surgical repair as soon as possible after hemodynamic stability has been achieved and infection has been controlled is recommended, to maximize the likelihood of successful outcomes. 
